In this setting, we found a positive correlation between circulating naive CD4+ T cells and baseline FVC, and reduced levels of both circulating naive CD4+ and CD8+ T cells in IPF progressors at both recruitment and a trend in the follow-up, despite the use of anti-fibrotic treatment. This evidence concerns the gene CD8A and idiopathic pulmonary fibrosis.